Nvidia CEO says being locked out of China AI market would be ‘tremendous loss’

Nvidia CEO says being locked out of China AI market would be ‘tremendous loss’


Nvidia CEO, Jensen Huang, speaks during an interview on CNBC’s ‘Power Lunch’ on May 6, 2025.

CNBC

Nvidia CEO Jensen Huang said on Tuesday that China’s artificial intelligence market will likely reach about $50 billion in the next two to three years, and that missing out on it would be a “tremendous loss.”

Huang said being able to sell into China would bring back revenue, taxes, and “create lots of jobs here in the United States.”

“We just have to stay agile,” Huang told CNBC’s Jon Fortt, in an interview alongside ServiceNow CEO Bill McDermott. The tech execs were in Las Vegas for ServiceNow’s Knowledge 2025 conference. “Whatever the policies are of the government, whatever is in the best interest of our country, we’ll support,” Huang said.

Nvidia is the leading provider of graphics processing units (GPUs), which have powered the AI boom and lifted the company’s market cap to almost $3 trillion. Last month, the Trump administration restricted the shipment of Nvidia’s H20 chips to China without a license. That technology, which is related to the Hopper chips used in the rest of the world, was developed to comply with previous U.S. export restrictions.

Nvidia said it would take a $5.5 billion quarterly charge due to the restriction, the strongest sign so far that the company’s historic growth could be slowed because of U.S.-China trade tensions. Later in April, Huang said at a tech conference in Washington, D.C., that China is “not behind” in AI, and that Huawei is “one of the most formidable technology companies in the world.”

Shares of Nvidia are down about 15% so far this year after almost tripling in 2023. The company is set to report earnings on May 28. Analysts expect to see revenue growth of 65% from a year earlier to $43.1 billion, according to LSEG. While Nvidia is still expanding much faster than its megacap peers, growth is slowing, as the company reported a revenue increase of more than 260% a year ago.

“The world is right now hungry, anxious to engage AI,” Huang said on Tuesday. “Let us get the American AI out in front of everybody right now.”

WATCH: CNBC’s full interview with Nvidia CEO Jensen Huang

Watch CNBC’s full interview with Nvidia CEO Jensen Huang and ServiceNow CEO Bill McDermott



Source

Google joins Microsoft in telling users Anthropic is still available outside defense projects
World

Google joins Microsoft in telling users Anthropic is still available outside defense projects

Google CEO Sundar Pichai gestures to the crowd during Google’s annual I/O developers conference in Mountain View, California, on May 20, 2025. David Paul Morris | Bloomberg | Getty Images Google said it will continue offering Anthropic’s artificial intelligence technology for clients, excluding for defense work, a day after Microsoft issued a similar statement to […]

Read More
Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide
World

Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide

The U.S. and Israel are showing signs of escalating their war against Iran – a move that could batter a variety of assets, even traditional safe havens. To protect their portfolios, investors can snap up stocks from an oft-shorted sector: pharmaceuticals, UBS analysts say. Since the first strikes last Saturday, the Iran War has roiled […]

Read More
Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’
World

Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’

Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management in adults and adolescents. (Photo by Steve Christo – Corbis/Corbis via Getty Images) Steve Christo – Corbis | Corbis News | Getty Images The chief executive of drugmaker Zealand Pharma sought to calm investors about the latest […]

Read More